Caxton Associates (New York)’s Novanta NOVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NOVT
CCA
Caxton Associates (New York)'s NOVT Position: Q3 2019 in Review
Caxton Associates (New York) sold out of Novanta (NOVT) in Q3 2019, closing a stake of 3,479 shares — an estimated $328K sold.
Caxton Associates (New York) first reported a position in NOVT in Q3 2017 and held it in 2 quarters. The position peaked at $328K in Q2 2019. 169 funds tracked by Wall St. Rank hold NOVT as of Q3 2019.
- Caxton Associates (New York) reported no remaining Novanta position as of Q3 2019 after selling out during the quarter.
- Caxton Associates (New York) sold 3,479 Novanta shares in Q3 2019, an estimated $328K.
- Caxton Associates (New York) first reported a position in Novanta in Q3 2017 and held it in 2 quarters.
- Caxton Associates (New York)'s Novanta position peaked at $328K in Q2 2019.
- 169 funds tracked by Wall St. Rank held Novanta as of Q3 2019.
Based on Caxton Associates (New York)'s 13F filing for Q3 2019, filed 14 Nov 2019.